17OHP for Reduction of Neonatal Morbidity Due to Preterm Birth (PTB) in Twin and Triplet Pregnancies
Public ClinicalTrials.gov record NCT00163020. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
17-Alpha-Hydroxyprogesterone Caproate for Reduction of Neonatal Morbidity Due to Preterm Birth in Twin and Triplet Pregnancies - A Concurrent Randomized Double-blinded Clinical Trial
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Hypothesis: Among women with twin or triplet pregnancies, weekly injections of 17-alpha-hydroxyprogesterone caproate (17OHP), started before 24 weeks of gestation, will reduce neonatal morbidity by reducing the rate of preterm delivery. This study involves two concurrent double-blinded randomized clinical trials of 17OHP versus placebo. Each trial will test the efficacy and safety of 17OHP in women with a specific risk factor for preterm birth. The two risk factors to be studied are: 1. Twin pregnancy 2. Triplet pregnancy
Study identification
- NCT ID
- NCT00163020
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Enrollment
- 321 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2004 (Type not available)
- Primary completion
- Aug 2009 (Actual)
- Completion
- Aug 2009 (Actual)
- Last update posted
- Apr 11, 2016
2004 – 2009
United States locations
- U.S. sites
- 18
- U.S. states
- 8
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Banner Good Samaritan Hospital | Phoenix | Arizona | 85006 | — |
| Tucson Medical Center | Tucson | Arizona | 85712 | — |
| Saddleback Memorial Medical Center | Laguna Hills | California | 92653 | — |
| Long Beach Memorial Medical Center | Long Beach | California | 90801-1428 | — |
| University of Southern California-Irvine Medical Center | Orange | California | 92868 | — |
| Good Samaritan Hospital | San Jose | California | 95124 | — |
| Swedish Medical Center | Denver | Colorado | 80110 | — |
| Presbyterian/St Luke's Hospital | Denver | Colorado | 80218 | — |
| Rose Medical Center | Denver | Colorado | 80220 | — |
| Skyridge Medical Center | Lonetree | Colorado | 80124 | — |
| Mercy Medical Center | Des Moines | Iowa | 50314 | — |
| Saint Luke's Hospital, Kansas City | Kansas City | Missouri | 64111 | — |
| Erlanger Medical Center | Chattanooga | Tennessee | 37403 | — |
| Baylor University Medical Center | Dallas | Texas | 75246 | — |
| Harris Methodist Fort Worth Hospital | Fort Worth | Texas | 76104 | — |
| Evergreen Hospital | Kirkland | Washington | 98034 | — |
| Swedish Medical Center | Seattle | Washington | 98122-4307 | — |
| Tacoma General Hospital | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00163020, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 11, 2016 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00163020 live on ClinicalTrials.gov.